Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K, Zackin R, Von Roenn JH, Chesney MA, Egorin MJ, Sattler FR, Benson CA, Liu T, Umbleja T, Shriver S, Auchus RJ, Schambelan M; ACTG 313 Study Team. Mulligan K, et al. J Clin Endocrinol Metab. 2007 Feb;92(2):563-70. doi: 10.1210/jc.2006-0954. Epub 2006 Nov 7. J Clin Endocrinol Metab. 2007. PMID: 17090640 Clinical Trial.
Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS; AIDS Clinical Trials Group 329 Study Team; National Institute of Allergy and Infectious Diseases Adult AIDS Clinical Trials Group. Mulligan K, et al. Arch Intern Med. 2005 Mar 14;165(5):578-85. doi: 10.1001/archinte.165.5.578. Arch Intern Med. 2005. PMID: 15767536 Clinical Trial.
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.
Sattler FR, Rajicic N, Mulligan K, Yarasheski KE, Koletar SL, Zolopa A, Alston Smith B, Zackin R, Bistrian B; ACTG 392 Study Team. Sattler FR, et al. Among authors: mulligan k. Am J Clin Nutr. 2008 Nov;88(5):1313-21. doi: 10.3945/ajcn.2006.23583. Am J Clin Nutr. 2008. PMID: 18996868 Free PMC article. Clinical Trial.
The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.
Mulligan K, Khatami H, Schwarz JM, Sakkas GK, DePaoli AM, Tai VW, Wen MJ, Lee GA, Grunfeld C, Schambelan M. Mulligan K, et al. J Clin Endocrinol Metab. 2009 Apr;94(4):1137-44. doi: 10.1210/jc.2008-1588. Epub 2009 Jan 27. J Clin Endocrinol Metab. 2009. PMID: 19174500 Free PMC article.
Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, Li X, Lang T, Grunfeld C, Schwarz JM, Schambelan M. Rao MN, et al. Among authors: mulligan k. J Clin Endocrinol Metab. 2010 Sep;95(9):4361-6. doi: 10.1210/jc.2009-2502. Epub 2010 Jul 7. J Clin Endocrinol Metab. 2010. PMID: 20610601 Free PMC article. Clinical Trial.
Subchronic sleep restriction causes tissue-specific insulin resistance.
Rao MN, Neylan TC, Grunfeld C, Mulligan K, Schambelan M, Schwarz JM. Rao MN, et al. Among authors: mulligan k. J Clin Endocrinol Metab. 2015 Apr;100(4):1664-71. doi: 10.1210/jc.2014-3911. Epub 2015 Feb 6. J Clin Endocrinol Metab. 2015. PMID: 25658017 Free PMC article. Clinical Trial.
399 results